Studi clinici su BPCO nello stato di Florida
28 studi su BPCO cercano partecipanti presso sedi nello stato di Florida.
Città nello stato di Florida
- Miami18 studi
- Orlando15 studi
- Hialeah8 studi
- Tampa7 studi
- Kendall7 studi
- Jacksonville6 studi
- West Palm Beach6 studi
- Ocala5 studi
- Doral4 studi
- Deltona4 studi
- St. Petersburg4 studi
- Boca Raton4 studi
- Naples3 studi
- Brandon3 studi
- Plantation3 studi
- Clearwater3 studi
- Cape Coral3 studi
- Palm Coast3 studi
Testo ufficiale dello studio (inglese)
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Meris Clinical Research- Site Number : 8400153, Brandon
- Hillcrest Medical Research- Site Number : 8400082, DeLand
- Finlay Medical Research - Greenacres- Site Number : 8400107, Greenacres City
- e altri 18
In reclutamentoFase 3
Età da 40 a 80 · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT07190222To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- International Clinical Research, Altamonte Springs
- Nature Coast Clinical Research, Crystal River
- Clinical Site Partners, LLC Leesburg dba Flourish Research, Leesburg
- e altri 2
In reclutamentoFase 2
Età da 40 a 85 · Tutti i sessi · Aggiornato il 30 set 2026 · NCT07684820A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Millennium Medical Research - Miami, Miami
- Deluxe Health Center, Miami Lakes
- Florida Institute For Clinical Research, LLC, Orlando
In reclutamentoFase 2
Età da 40 a 75 · Tutti i sessi · Aggiornato il 25 set 2026 · NCT07759245A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)
- GSK Investigational Site, Miami
- GSK Investigational Site, Tampa
In reclutamentoFase 3
Età da 40 a 80 · Tutti i sessi · Aggiornato il 25 set 2026 · NCT07780656A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- University of Miami Dermatology Clinical Trials Unit- Site Number : 8400015, Miami
- Finlay Medical Research- Site Number : 8400010, Miami
In reclutamentoFase 4
Età da 40 a 85 · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07053423Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Helix Biomedics- Site Number : 8400065, Boynton Beach
- Beautiful Minds Clinical Research Center- Site Number : 8400017, Cutler Bay
- Eastern Medical Group Research- Site Number : 8400020, Fort Myers
- e altri 10
In reclutamentoFase 3
Età da 40 a 80 · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07190209A Study to Evaluate the Long-term Safety and Efficacy of Lunsekimig in Adult Participants With Chronic Obstructive Pulmonary Disease (COPD)
- Helix Biomedics- Site Number : 8403065, Boynton Beach
In reclutamentoFase 3
Età da 40 a 80 · Tutti i sessi · Aggiornato il 21 set 2026 · NCT07793409An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
- Orlando Health, Orlando
In reclutamento
Età da 40 a 80 · Tutti i sessi · Aggiornato il 17 set 2026 · NCT06035120A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
- WB Contracted Clinical Research Site, Miami Lakes
In reclutamentoFase 2
Età da 40 a 80 · Tutti i sessi · Aggiornato il 15 set 2026 · NCT07646587A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Brandon
- Research Site, Cape Coral
- Research Site, Clearwater
- e altri 17
In reclutamentoFase 2
Età 40 e oltre · Tutti i sessi · Aggiornato il 9 set 2026 · NCT07082738A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)
- GSK Investigational Site, Doral
In reclutamentoFase 3
Età da 40 a 80 · Tutti i sessi · Aggiornato il 9 set 2026 · NCT07780669Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- University of Florida, Jacksonville
In reclutamentoFase 2
Età 40 e oltre · Tutti i sessi · Aggiornato il 4 set 2026 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Bay Pines
- Research Site, Boynton Beach
- Research Site, Jacksonville
- e altri 5
In reclutamentoFase 3
Età da 40 a 80 · Tutti i sessi · Aggiornato il 3 set 2026 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Clearwater
- Research Site, Cutler Bay
- Research Site, Cutler Bay
- e altri 9
In reclutamentoFase 3
Età da 40 a 80 · Tutti i sessi · Aggiornato il 3 set 2026 · NCT06883305A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Finlay Medical Research, Greenacres City
- Clinical Research Specialists LLC, Kissimmee
- Advanced Pulmonary Research Institute, Loxahatchee Groves
- e altri 9
In reclutamentoFase 2/3
Età da 35 a 80 · Tutti i sessi · Aggiornato il 31 ago 2026 · NCT07363694Rademikibart IV for Acute Asthma and COPD Exacerbation
- Columbus Clinical Services, LLC, Miami
- Pharmax Research of South Florida, Inc., Miami
In reclutamentoFase 2
Età da 18 a 85 · Tutti i sessi · Aggiornato il 27 ago 2026 · NCT07705737A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Boynton Beach
- Research Site, Bradenton
- Research Site, Cape Coral
- e altri 25
In reclutamentoFase 3
Età da 40 a 80 · Tutti i sessi · Aggiornato il 26 ago 2026 · NCT06283966Alpha-1 Research Registry
- Alpha-1 Foundation, Coral Gables
In reclutamentoStudio osservazionale
Tutte le età · Tutti i sessi · Aggiornato il 19 ago 2026 · NCT04157049A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 103, Gainesville
- GC2501 Study Site 105, Miami
In reclutamentoFase 3
Età da 18 a 80 · Tutti i sessi · Aggiornato il 11 ago 2026 · NCT07555483STRIVE Post-Market Registry Study
- University of Miami, Coral Gables
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 3 ago 2026 · NCT04302272eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Brandon
- GSK Investigational Site, Crystal River
- GSK Investigational Site, Doral
- e altri 8
In reclutamentoFase 3
Età da 40 a 75 · Tutti i sessi · Aggiornato il 28 lug 2026 · NCT07177339Physiologic Effects of Nasal High Flow on Exercise Tolerance in COPD
- University of Miami, Miami
In reclutamento
Età da 18 a 100 · Tutti i sessi · Aggiornato il 22 giu 2026 · NCT06578156Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
- Mayo Clinic Jacksonville, Jacksonville
In reclutamento
Età da 40 a 80 · Tutti i sessi · Aggiornato il 28 apr 2026 · NCT07051707Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- Mayo Clinic, Jacksonville
- Orlando Health, Orlando
In reclutamento
Età da 40 a 84 · Tutti i sessi · Aggiornato il 24 apr 2026 · NCT06891755Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Brooksville
- GSK Investigational Site, Doral
- GSK Investigational Site, Fort Lauderdale
- e altri 15
In reclutamentoFase 3
Età da 40 a 80 · Tutti i sessi · Aggiornato il 9 apr 2026 · NCT06961214Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)
- GSK Investigational Site, Loxahatchee Groves
- GSK Investigational Site, Miami
In reclutamentoFase 3
Età da 40 a 80 · Tutti i sessi · Aggiornato il 8 ott 2025 · NCT06959095Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Hillcrest Medical Research, DeLand
- Universal Axon Clinical Research, Doral
- I.H.S Health, LLC, Kissimmee
- e altri 3
In reclutamentoStudio osservazionale
Età 50 e oltre · Tutti i sessi · Aggiornato il 5 ago 2025 · NCT06122077myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- University of Florida, Jacksonville, Jacksonville
- Alloy Clinical Research, Kissimmee
- Reliable Research, Inc., Miami
- e altri 2
In reclutamento
Età 30 e oltre · Tutti i sessi · Aggiornato il 6 feb 2025 · NCT05204888Fonte: ClinicalTrials.gov, dati recuperati il 2 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.